BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3417410)

  • 1. Two types of visual dysfunction in autosomal dominant retinitis pigmentosa.
    Kemp CM; Jacobson SG; Faulkner DJ
    Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1235-41. PubMed ID: 3417410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse loss of rod function in autosomal dominant retinitis pigmentosa with pro-347-leu mutation of rhodopsin.
    Apfelstedt-Sylla E; Kunisch M; Horn M; Rüther K; Gal A; Zrenner E
    Ger J Ophthalmol; 1992; 1(5):319-27. PubMed ID: 1477634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant retinitis pigmentosa in a large family: a clinical and molecular genetic study.
    Rosas DJ; Roman AJ; Weissbrod P; Macke JP; Nathans J
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3134-44. PubMed ID: 8045708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa.
    Jacobson SG; Kemp CM; Cideciyan AV; Macke JP; Sung CH; Nathans J
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2521-34. PubMed ID: 8163341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant retinitis pigmentosa caused by the threonine-17-methionine rhodopsin mutation: retinal histopathology and immunocytochemistry.
    Li ZY; Jacobson SG; Milam AH
    Exp Eye Res; 1994 Apr; 58(4):397-408. PubMed ID: 7925677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation.
    Rosenfeld PJ; Hahn LB; Sandberg MA; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2186-92. PubMed ID: 7558711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Neidhardt J; Barthelmes D; Farahmand F; Fleischhauer JC; Berger W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1630-5. PubMed ID: 16565402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal activation and inactivation mechanisms of rod transduction in patients with autosomal dominant retinitis pigmentosa and the pro-23-his mutation.
    Birch DG; Hood DC; Nusinowitz S; Pepperberg DR
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1603-14. PubMed ID: 7601641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between rod perimetric thresholds and full-field rod ERGs in retinitis pigmentosa.
    Birch DG; Herman WK; deFaller JM; Disbrow DT; Birch EE
    Invest Ophthalmol Vis Sci; 1987 Jun; 28(6):954-65. PubMed ID: 3583634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene.
    Jacobson SG; Buraczynska M; Milam AH; Chen C; Järvaläinen M; Fujita R; Wu W; Huang Y; Cideciyan AV; Swaroop A
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1983-97. PubMed ID: 9331262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
    Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rod sensitivity relative to cone sensitivity in retinitis pigmentosa.
    Massof RW; Finkelstein D
    Invest Ophthalmol Vis Sci; 1979 Mar; 18(3):263-72. PubMed ID: 422332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked retinitis pigmentosa: functional phenotype of an RP2 genotype.
    Jacobson SG; Roman AJ; Cideciyan AV; Robey MG; Iwata T; Inana G
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3481-92. PubMed ID: 1464493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic effects of the Q64ter rhodopsin mutation in retinitis pigmentosa.
    Milam AH; Li ZY; Cideciyan AV; Jacobson SG
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):753-65. PubMed ID: 8603860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique characteristics of two types of retinitis pigmentosa patients with different rod sensitivities.
    Takahashi H; Miyake Y; Horiguchi M; Tomida N; Takakuwa H
    Jpn J Ophthalmol; 2005; 49(2):114-20. PubMed ID: 15838727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa.
    Rosenfeld PJ; Cowley GS; McGee TL; Sandberg MA; Berson EL; Dryja TP
    Nat Genet; 1992 Jun; 1(3):209-13. PubMed ID: 1303237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between visual sensitivity and rhodopsin density in retinitis pigmentosa.
    Perlman I; Auerbach E
    Invest Ophthalmol Vis Sci; 1981 Jun; 20(6):758-65. PubMed ID: 7239846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acuity recovery and cone pigment regeneration after a bleach in patients with retinitis pigmentosa and rhodopsin mutations.
    Sandberg MA; Pawlyk BS; Berson EL
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2457-61. PubMed ID: 10476820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.